Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Enza Biotech AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -576 Less Arrow -802 More Arrow -777
EBITDA -552 Less Arrow -747 More Arrow -721
Total assets 688 Less Arrow 499 Less Arrow 495
Current assets 688 Less Arrow 208 Less Arrow 163
Current liabilities 136 More Arrow 160 Less Arrow 93
Equity capital 552 Less Arrow 339 More Arrow 401
- share capital 24 More Arrow 25 Equal arrow 25
Employees (average) 5 Equal arrow 5 Equal arrow 5

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 80.2% Less Arrow 67.9% More Arrow 81.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -83.7% Less Arrow -160.7% More Arrow -157.0%
Current ratio 505.9% Less Arrow 130.0% More Arrow 175.3%
Return on equity (ROE) -104.3% Less Arrow -236.6% More Arrow -193.8%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.